2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Most active institutional investors by number of deals

Investor Profile Country Deals
Pfizer Inc United States 23
Abbott Laboratories United States 9
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. United States 7
Royal Veterinary College Various Research United Kingdom 7
Celgene Corp Biopharmaceutical company committed to improving the lives of patients worldwide. United States 6
Alkermes Inc Ireland 4
Bayer AG Germany 3
Cubist Pharmaceuticals Inc Cubist Pharmaceuticals is a bio-pharmaceutical company. 3
Cytyc Corp United States 2
Life Technologies Inc United States 2
McKesson Corp United States 2
Medicis Pharmaceutical Corp United States 2
Nektar Therapeutics United States 2
Swedish Orphan Biovitrum AB Swedish pharmaceutical company with a product portfolio consisting of some 60 orphan and specialty pharmaceuticals Sweden 2
Abbie Inc 1
Abcam PLC Abcam plc is a producer and distributor of research-grade antibodies and associated products. United States 1
Actavis PLC United States 1
Agenus Inc United States 1
Alnylam Pharmaceuticals Inc United States 1
American Medical Systems Inc United States 1

Pages

Selected companies

Company type: 
Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.
Company type: 
Biopharmaceuticals company focused on the development of novel therapeutics for respiratory disorders.
Company type: 
Biopharmaceutical company discovering, developing and commercializing cancer therapeutics.
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products